InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-22.0%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Bigora Sian, Directeur du Développement. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. Cumulatively, 9 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €14k. Activity tracked since 1 January 2026. The latest transaction was disclosed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bigora Sian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
1,986 股@ US$2.690.090% mcap100.0% 占其流量Common StockSEC:0000897069-26-001000:0
标准退出：2026年7月29日 (T+90)
1,799 股@ US$2.970.089% mcap49.8% 占其流量Common StockSEC:0000897069-26-000904:0
标准退出：2026年7月14日 (T+90)
2,107 股@ US$2.53533.7% 占其流量Common StockSEC:0000897069-26-000743:0
标准退出：2026年6月29日 (T+90)
249 股0Common StockSEC:0000897069-26-000218:0
15,059 股Common StockSEC:0000897069-25-000789:0
1,675 股Common StockSEC:0000897069-24-001615:0
1,675 股Common StockSEC:0000897069-24-000919:0
7,601 股Common StockSEC:0001567619-22-015305:0
7,601 股Common StockSEC:0001567619-21-014751:0
9 条申报中的 9 条
About Bigora Sian
Bigora Sian is Chief Development Officer and appears in 9 filings in total. Across the 9 recent filings available, they concern Processa Pharmaceuticals, Inc., with EUR 13,694 of buys and EUR 0 of sells, mainly option exercises, between 2021-08-09 and 2026-05-01.
